Have a read up on Immunomedics. Imugene is not quite in the same position yet but is heading that way rapidly. If Imugene was valued at the same price as the Immunomedics take over price, it would be around the US$5 mark.
In the linked article below, there's a paragraph on trial results with an interesting similarity to the Imugene HER-Vaxx ph2 trial interim update.
https://www.gilead.com/news-and-press/press-room/press-releases/2020/9/gilead-sciences-to-acquire-immunomedics
"In the Phase 3 ASCENT study, which was halted early due to efficacy based on the unanimous recommendation of the independent Data Safety Monitoring Committee, Trodelvy significantly improved progression-free survival (PFS) and overall survival (OS) in previously treated patients with advanced mTNBC."
Why IMU is a multi multi bagger, page-978
-
- There are more pages in this discussion • 25,960 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.004(8.16%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.5¢ | 4.8¢ | $1.798M | 35.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 2193808 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 605064 | 3 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |